Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder

Archives of General Psychiatry

Volumn 59, Issue 12, 2002, Pages 1098-1104

  Katon, Wayne J ^a   Roy Byrne, Peter ^b   Russo, Joan ^a   Cowley, Deborah ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ANXIETY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MENTAL HEALTH; OUTPATIENT; PANIC; PRIMARY MEDICAL CARE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

ADULT; AMBULATORY CARE; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PAROXETINE; PATIENT CARE TEAM; PATIENT EDUCATION; PRIMARY HEALTH CARE; PSYCHIATRY; PSYCHOTHERAPY; REFERRAL AND CONSULTATION; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; WASHINGTON;

EID: 0036894551     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.12.1098     Document Type: Article

References (45)

1. Spitzer RL, Williams JB, Kroenke K, Linzer M, DeGruy FV III, Hahn SR, Brody D, Johnson JG. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. JAMA. 1994;272:1749-1756.
2. Simon GE. Psychiatric disorder and functional somatic symptoms as predictors of health care use. Psychiatr Med. 1992;10:49-59.
3. Katon W, Von Korff M, Lin E, Lipscomb P, Russo J, Wagner E, Polk E. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry. 1990;12:355-362.
4. Katon W, Hall ML, Russo J, Cormier L, Hollifield M, Vitaliano PP, Beitman BD. Chest pain: Relationship of psychiatric illness to coronary arteriographic results. Am J Med. 1988;84:1-9.
5. Simon GE, Von Korff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area Study. Am J Psychiatry. 1991;148:1494-1500.
6. Barsky AJ, Clear PD, Coeytaux RR, Ruskin JN. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med. 1994;9:306-313.
7. Sherbourne C, Wells K, Judd L. Functioning and well-being of patients with panic disorder. Am J Psychiatry. 1996;153:213-218.
8. Kouzis A, Eaton W. Psychopathology and the initiation of disability payments. Psychiatr Serv. 2000;51:908-913.
9. Roy-Byrne PP, Stein MB, Russo J, Mercier E, Thomas R, McQuaid J, Katon WJ, Craske MG, Bystritsky A, Sherbourne CD. Panic disorder in the primary care setting: Comorbidity, disability service utilization, and treatment. J Clin Psychiatry. 1999;60:492-499.
10. Meredith LS, Sherbourne CD, Jackson CA, Camp P, Wells KB. Treatment typically provided for comorbid anxiety disorder. Arch Fam Med. 1997;6:231-237.
11. Roy-Byrne P, Katon W, Cowley D, Russo J. A randomized effectiveness trial of an intervention for panic disorder in primary care. Arch Gen Psychiatry. 2001; 58:869-876.
12. Von Korff M, Katon W, Bush T, Lin EH, Simon GE, Saunders K, Ludman E, Walker E, Unützer J. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med. 1997;60:143-149.
13. Simon G, Katon W, Von Korff M, Unützer J, Lin EHB, Walker E, Bush T, Rutter C, Ludman E. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry. 2001;158:16381644.
14. Stein MB, Roy-Byrne PP, McQuaid JR, Laffaye C, Russo J, McCahill ME, Katon W, Craske M, Bystritsky A, Sherbourne CD. Development of a brief diagnostic screen for panic disorder in primary care. Psychosom Med. 1999; 61:359-364.
15. Roy-Byrne P, Stein M, Bystrisky A, Katon W. Pharmacotherapy of panic disorder: Proposed guidelines for the family physician. J Am Board Fam Pract. 1998; 11:282-290.
16. Katon W, Von Korff M, Lin E, Walker E, Simon G, Bush T, Robinson P, Russo J. Collaborative management to achieve treatment guidelines: Impact on depression in primary care. JAMA. 1995;273:1026-1031.
17. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, Simon G, Walker E. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924-932.
18. World Health Organization. Composite International Diagnostic Interview (CIDI) 2.1. Geneva, Switzerland: World Health Organization; 1997.
19. Blazer D, Kessler R, McGonagle K, Swarz M. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry. 1994;151:979-986.
20. Wittchen HU, Kessler R, Zhao S. Reliability and clinical validity of UM-CIDI DSMIII-R generalized anxiety disorder. J Psychiatr Res. 1995;29:95-110.
21. Wittchen HU, Kessler R, Abelson J. Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychot Med. 1996;25:1169-1177.
22. Wells K, Burnam M, Leake B. Agreement between face-to-face and telephoneadministered versions of the depression section of the NIMH Diagnostic Interview Schedule. J Psychiatr Res. 1988;22:207-220.
23. Peterson RA, Reiss S. Anxiety Sensitivity Index Test Manual. 2nd ed. Worthington, Ohio: International Diagnostic Systems; 1992.
24. Otto MW, Reilly-Harrington NA. The impact of anxiety sensitivity. In: Taylor S, ed. Anxiety Sensitivity: Theory, Research and Treatment of the Fear of Anxiety. Hillsdale, NJ: Lawrence A Erlbaum Associates; 1999:321-336.
25. Hazen A, Walker E, Eldridge G. Anxiety sensitivity and treatment outcome in panic disorder. Anxiety. 1996;2:34-39.
26. Shear MK, Maser JD. Standardized assessment for panic disorder research: A conference report. Arch Gen Psychiatry. 1994;51:346-354.
27. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF III. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41:237-248.
28. Wells K. The design of Partners in Care: Evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol. 1999;34:20-29.
29. RBRVS EZ-Fees, 2000. Milwaukee, Wis: Wasserman Medical Publishers Ltd; 2000.
30. Lave J, Frank R, Schulberg H, Kamlet M. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry. 1998;55:645-651.
31. Blough D, Madden C, Horinbrook M. Modeling risk using generalized linear models. J Health Econ. 1999;18:151-173.
32. Pollack S, Bruce P, Bornstein M, Lieberman J. The resampling method of statistical analysis. Psychopharmacol Bull. 1994;30:227-234.
33. Manning W, Fryback D, Weinstein M. Deflecting uncertainty in cost effectiveness analysis. In: Gold M, Siegel J, Russel L, Weinstein M, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press Inc; 1996.
34. Simon G, Manning W, Katzelnick D, Pearson S, Henk H, Heestand C. Costeffectiveness of systemic depression treatment for high utilizers of primary care. Arch Gen Psychiatry. 2001;58:181-187.
35. Katon W. Panic disorder: Relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry. 1996;57(suppl 10):11-18.
36. Barsky A, Cleary P, Coeytaux R, Ruskin J. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med. 1994;9:306-313.
37. Walker E, Gelfand A, Gelfand M, Katon W. Psychiatric diagnoses, sexual and physical victimization and disability in patients with irritable bowel syndrome and inflammatory bowel disease. Psychol Med. 1995;25:1259-1267.
38. Fogarty J, Engel C Jr, Russo J, Simon G, Katon W. Hypertension and pheochromocytoma testing: The association with anxiety disorders. Arch Fam Med. 1994; 3:55-60.
39. Stein M, Asmundson G, Ireland D, Walker J. Panic disorder in patients attending a clinic for vestibular disorders. Am J Psychiatry. 1994;151:1697-1700.
40. Klerman G, Weissman M, Ouellette R, Johnson J, Greenwald S. Panic attacks in the community: Social morbidity and health care utilization. JAMA. 1991;265: 742-746.
41. Markowitz J, Weissman M, Ouellette R, Lish J, Klerman G. Quality of life in panic disorder. Arch Gen Psychiatry. 1989;46:984-992.
42. Mendlowicz M, Stein M. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157:669-682.
43. Katon W, Hollifiled M, Chapman T, Mannuza S, Ballengar J, Fyer A. Infrequent panic attacks: Psychiatric comorbidity, personality characteristics and functional disability. J Psychiatry Res. 1995;29:121-131.
44. Salvador-Carulla L, Sequi J, Fernandez-Cato P, Canet J. Costs and offset effect in panic disorders. BrJ Psychiatry. 1995;166(suppl 27):23-28.
45. Schoenbaum M, Unützer J, Sherbourne C, Duan N, Rubinstein L, Miranda J, Meredith LS, Carney MF, Wells K. Cost-effectiveness of practice-initiated quality improvement for depression: Results of a randomized controlled trial. JAMA. 2001; 286:1325-1330.